Two Case Reports of Intravenous Leiomyomatosis with Hyaluronan Expression
Open Access
- 1 January 2018
- journal article
- case report
- Published by Wiley in Case Reports in Obstetrics and Gynecology
- Vol. 2018 (1) , 4039183
Abstract
Intravenous leiomyomatosis (IVL) is a rare benign neoplasm. Herein, we describe two cases of IVL at different levels of progression. The tumor in Case 1 was extensive, invading the right atrium after a hysterectomy for a uterine myoma. The tumor temporarily responded to hormonal treatment; however, tumor regrowth occurred. In contrast, the tumor in Case 2 extended only to the pelvic veins and was revealed preoperatively. Hysterectomy and bilateral salpingo‐oophorectomy were performed, resulting in the complete surgical resection of the tumor. In Case 2, no recurrence has been observed. Tumor samples were evaluated for hyaluronan expression using Alcian blue staining (with and without hyaluronidase digestion). The tumor in Case 1 stained strongly positive for hyaluronan while the tumor in Case 2 stained weakly positive for hyaluronan. In contrast, a large non‐IVL uterine leiomyoma (control) stained negative for hyaluronan. These results suggest a relationship between tumor hyaluronan expression and IVL progression, similar to that in other cancers.Keywords
This publication has 15 references indexed in Scilit:
- Hyaluronan: A modulator of the tumor microenvironmentCancer Letters, 2016
- Update on intravenous leiomyomatosis: report of five patients and literature reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- A Case of Uterine Leiomyoma with Intravenous Leiomyomatosis—Histological Investigation of the Pathological Condition—Pathology and Oncology Research, 2010
- A case of intravenous leiomyomatosis with high levels of hyaluronanJournal of Obstetrics and Gynaecology Research, 2010
- Smooth muscle tumors of the uterus: a practical approach.Archives of Pathology & Laboratory Medicine, 2008
- Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activationCardiovascular Research, 2006
- Increased hyaluronan and CD44 expressions in intravenous leiomyomatosisActa Obstetricia et Gynecologica Scandinavica, 2005
- Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts SurvivalThe American Journal of Pathology, 2000
- Intravenous leiomyomatosisJournal of Vascular Surgery, 1994
- Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis: A clinical and pathologic study of 14 casesCancer, 1975